What is InvoSurg?
InvoSurg Inc. operates within the medical device distribution landscape, bringing more than ten years of specialized experience to the cardiac surgery and extracorporeal life support markets. A key differentiator for InvoSurg is its strong emphasis on education and clinical training, with a substantial portion of its field team possessing robust clinical backgrounds, particularly in cardiac perfusion. This focus enables the company to effectively partner with leading industry innovators, delivering advanced and effective solutions to meet the intricate challenges faced by healthcare providers.
How much funding has InvoSurg raised?
InvoSurg has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in InvoSurg
PPP
Public-Private Partnership
What's next for InvoSurg?
The substantial late-stage funding secured by InvoSurg, highlighted by a recent major strategic investment, positions the company for significant growth and market expansion. This capital infusion is likely to fuel further development of its distribution network, enhance its educational and training initiatives, and potentially broaden its portfolio of innovative medical devices. The company's strategic focus on partnering with best-in-class industry leaders suggests a continued commitment to bringing cutting-edge solutions to the cardiac surgery and life support sectors, solidifying its role as a key player in the medical technology ecosystem.
See full InvoSurg company page
